5605-66-3

Basic information

• Product Name: 1,3,6',2''-tetra-N-benzyloxycarbonyl-kanamycin A
• Synonyms: 1,3,6',2''-tetra-N-benzyloxycarbonyl-kanamycin A
• CAS NO: 5605-66-3
• Molecular Weight: 1021.04
• Mol File: 5605-66-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1,3,6',2''-tetra-N-benzyloxycarbonyl-kanamycin A(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3,6',2''-tetra-N-benzyloxycarbonyl-kanamycin A(5605-66-3)
• EPA Substance Registry System: 1,3,6',2''-tetra-N-benzyloxycarbonyl-kanamycin A(5605-66-3)

Safety Data

• Hazardous Substances Data: 5605-66-3(Hazardous Substances Data)

Upstream product

• 501-53-1 benzyl chloroformate 
• 59-01-8 kanamycin A 
• 3847-27-6 Kanamycin A sulfate 
• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 

Downstream Products

• 1067640-79-2 1,3,6'-tri-N-benzyloxycarbonyl-3'',4''-N,O-carbonyl-kanamycin A 
• 67470-54-6 1,3,6'-tri-N-benzyloxycarbonyl-kanamycin A 
• 1067640-81-6 1,3-di-N-benzyloxycarbonyl-6',4'-N,O-carbonyl-kanamycin A 
• 1182844-39-8 1,3-di-N-benzyloxycarbonyl-kanamycin A 
• 1182844-40-1 1,3,6'-tri-N-benzyloxycarbonyl-kanamycin A-3''-N-succinamide 
• 69783-76-2 1L-N,N'-bis-benzyloxycarbonyl-O⁴-(3-amino-N,O²-carbonyl-O⁴,O⁶-cyclohexane-1,1-diyl-α-D-3-deoxy-glucopyranosyl)-O⁶-(6-amino-N,O⁴-carbonyl-α-D-6-deoxy-glucopyranosyl)-2-deoxy-streptamine 
• 78878-70-3 3'',2''-N,O-carbonyl-1,3,6'-tri-N-tosyl-6''-O-tritylkanamycin A 
• 78878-64-5 1,3,6'-tris(N-benzyloxycarbonyl)-3''-N-tosyl-6''-O-tritylkanamycin A 
• 78878-60-1 1,3,6',3''-tetrakis(N-benzyloxycarbonyl)-6''-O-tritylkanamycin A 
• 77833-75-1 C₆₀H₇₀N₄O₂₄ 
• 64978-01-4 1,3,6',3-tetrakis(N-benzyloxycarbonyl)-4,6-O-cyclohexylidenekanamycin A 
• 69783-64-8 1,3-di-N-benzyloxycarbonyl-6',4':3'',2''-di-N,O-carbonyl-kanamycin A 

Relevant articles and documents

Synthesis, separation, and characterization of amphiphilic sulfated oligosaccharides enabled by reversed-phase ion pairing LC and LC-MS methods

Synthesis of amphiphilic oligosaccharides is problematic because traditional methods for separating and purifying oligosaccharides, including sulfated oligosaccharides, are generally not applicable to working with amphiphilic sugars. We report here RPIP-L

Selective inhibition of bacterial and human topoisomerases by N-arylacyl O-sulfonated aminoglycoside derivatives

Numerous therapeutic applications have been proposed for molecules that bind heparin-binding proteins. Development of such compounds has primarily focused on optimizing the degree and orientation of anionic groups on a scaffold, but utility of these polya

A HIGHLY SELECTIVE N-PROTECTION STRATEGY FOR THE PREPARATION OF 1-N-ALKYLATED KANAMYCIN ANTIBIOTICS

An O to N acyl migration technique has been used to selectively acetylate the amino groups of the aminosugar rings of kanamycins A and B, leaving the amino groups on the 2-deoxy-streptamine ring unprotected.A formylation-deformylation process then convert